Headline
The latest stories from AHA Today.
The United States District Court for the District of Columbia ruled in favor of the AHA, holding that HHS must immediately halt the departments’ unlawful cuts to outpatient reimbursement rates for the remainder of 2022 for certain hospitals that participate in the 340B Drug Pricing Program.
The AHA and Federation of American Hospitals urged Congress to oppose H.R.1330/S.4130 and any other legislation that would repeal or weaken current law limiting self-referral to physician-owned hospitals.
Health and Human Services Secretary Xavier Becerra yesterday declared a public health emergency for Florida as Hurricane Ian approaches, and waived or modified certain Medicare, Medicaid and Children’s Health Insurance Program requirements to ensure sufficient health care items and services are…
Pfizer has submitted a request for the Food and Drug Administration to authorize a 10-microgram booster dose of its bivalent COVID-19 vaccine booster for emergency use in children aged 5-11.
The Medicare Part A deductible for inpatient hospital services will increase by $44 in calendar year 2023, to $1,600, the Centers for Medicare & Medicaid Services announced today.
AHA today submitted comments to the Medicare Payment Advisory Commission as the panel considers potential changes to the Medicare hospital wage index, Part B drug payment policies and the Medicare Advantage program.
The AHA, American Medical Association and Medical Group Management Association today urged the Centers for Medicare & Medicaid Services not to include a convening/co-provider framework when implementing the Advanced Explanation of Benefits and insured good faith estimate provisions under the No…
AHA yesterday thanked Reps. Jason Crow, D-Colo., and Brian Fitzpatrick, R-Pa., for introducing a House companion to the Healthcare Cybersecurity Act, AHA-supported legislation that would improve collaboration and coordination between the Cybersecurity and Infrastructure Security Agency and…
Health care providers who treat uninsured or underinsured patients with commercially procured bebtelovimab, a COVID-19 monoclonal antibody therapy for outpatients at high risk for hospitalization, may be eligible for free replacement doses from the Department of Health and Human Services. HHS plans…
The Centers for Medicare & Medicaid Services Friday reopened the comment period for a 2020 interim final rule that set forth certain requirements for states to claim a temporary increase in federal matching funds for their Medicaid programs under the Families First Coronavirus Response Act.